AI assistant
Sending…
GALECTIN THERAPEUTICS INC — Director's Dealing 2011
Oct 14, 2011
33422_dirs_2011-10-14_36f843a9-48e4-4989-97f5-6e078abf11a7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT.OB)
CIK: 0001133416
Period of Report: 2011-10-12
Reporting Person: Rubin Marc (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-12 | Stock Option (Right to Buy) | $0.97 | A | 98970 | Acquired | 2021-10-12 | Common Stock (98970) | Direct |
Footnotes
F1: The options vest quarterly in eight equal installments beginning January 12, 2011.
More from GALECTIN THERAPEUTICS INC
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Mar 31
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 17
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 21